A 7 month old infant with pancreatitis and ascites was managed successfully with subcutaneous octreotide and external drainage of a pseudocyst. An endoscopic retrograde cholangiopancreatographic examination showed no congenital abnormality and was consistent with chronic pancreatitis. Octreotide has a possible therapeutic role in pancreatic ascites. (Arch Dis Child 1993;68:135-6) Pancreatitis in infants and children is a rare but serious condition and presents a complex challenge to clinicians. Trauma is the most common aetiology, however the causes are diverse. Management is supportive and includes bowel rest and parenteral nutrition. More recently, the use of pancreatic secretory inhibitors has been advocated. decrease in the production of ascites such that further paracentesis was not required.
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Serial ultrasound and computed tomography showed an oedematous pancreas and a gradually enlarging pancreatic pseudocyst. This was drained under ultrasound control by insertion of a percutaneous catheter into the cyst through the body of the stomach. Subsequent ultrasound scans showed full resolution of the pseudocyst. Enteral feeds were reintroduced without relapse and the child made a complete and uneventful recovery.
An endoscopic retrograde cholangiopancreatographic examination performed six weeks after resolution of symptoms showed normal pancreatic anatomy but diffuse dilatation of the duct consistent with chronic pancreatitis.
There has been no recurrence of symptoms over a 12 month follow up period and exocrine pancreatic function monitored by serial faecal chymotrypsin concentrations remains normal.
Case report A boy of 7 When medical management has failed to control ascites, a surgical drainage procedure is usually required. This is associated with a significant mortality and the use of octreotide may reduce the need for surgical intervention.
Octreotide is a synthetic octapeptide analogue of somatostatin and shares its biological activity as a result of four common amino acids. The mode of action seems to be at two levels, by a direct receptor specific inhibition of adenylcyclase activity and by inhibition of calcium flux across cell membranes. The exact physiological role of somatostatin and octreotide on the gastrointestinal tract has not been precisely defined, however, somatostatin and octreotide can be regarded as 'pan inhibitors' of gastrointestinal, pancreatic exocrine, and endocrine functions, and gastrointestinal motility.4 Action on the human pancreas appears to be by a reduction of enzyme secretion, with no reduction in bicarbonate secretion. 5 Octreotide's advantage over somatostatin is a much longer half life (1 to 2 hours compared with only 2 minutes). It can therefore be given by subcutaneous injection rather than continuous infusion. Somatostatin has been used with some benefit in the management of pancreatitis in adults,6 although further trials are needed to establish its exact role in treatment.
In our patient octreotide treatment resulted in a marked reduction in the production of ascitic fluid and improvement in the condition of the child. No side effects were seen. We suggest that octreotide may have a place in children with acute pancreatitis and its complications. The long term prognosis in this patient is uncertain but treatment with free radical scavengers has a possible role in preventing recurrence.7
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It has been shown by means of the breath hydrogen test that intestinal absorptive capacity for fructose is limited, partly depending on the presence of glucose.' Malabsorption of fructose would have clinical consequences, especially for toddlers, as they may consume relatively large amounts of apple juice. Discussion continues as to whether incomplete absorption of fructose in young children is normal, as opposed to a specific absorption defect.2 3 We therefore reinvestigated fructose absorption, using the breath hydrogen test, in children under 6 years of age.
Subjects and methods
The study group comprised 114 healthy children (59 boys). Mean age was 3 5 years (range 0 1-6-0). They were recruited from day care centres and kindergartens. The parents completed a questionnaire concerning actual diets and bowel habits.
Fifty seven children each were given 2 g/kg or 1 g/kg of fructose as a 20% solution after at least a six hour fast. The two groups were comparable in terms of age and sex. Breath samples were taken before fructose ingestion and at 30 minute intervals until 2 
